Back

Routinely available inflammation biomarkers as predictors of adverse outcomes following coronary angiography

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Interventional cardiology and biomarkers Outcome ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Eva Steinacher

Medical University of Vienna, Vienna (Austria)

4 More presentations in this session

Presentation thumbnail
High-sensitivity c-reactive protein to high-density lipoprotein cholesterol ratio and the risk of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention
Mr J. Liu (Guangzhou, CN)
Abstract Slides Video
Presentation thumbnail
Circulating intermediate monocytes increase after elective percutaneous coronary intervention
Doctor U. Bhalraam (Norfolk, GB)
Abstract Slides Video
Presentation thumbnail
Mortality after periprocedural myocardial injury and spontaneous myocardial infarction according to the levels of troponin increase: insights from a large PCI registry
Doctor A. Spirito (Lucerne, CH)
Abstract Slides Video
Presentation thumbnail
C-reactive protein levels and coronary in-stent restenosis: A systematic review and meta-analysis
Doctor H. Rai (Dublin 7, IE)
Abstract Slides Video

Access the full session

Session thumbnail
Interventional cardiology and biomarkers

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Percutaneous intervention is better than surgery in real life for most patients: pro
thumbnail
Congress Presentation
Association of PCI with outcomes in stable coronary artery disease
thumbnail
Congress Presentation
Prognostic impact of intravascular imaging in percutaneous coronary intervention according to atherothrombotic risk

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources